Skip to content

Search for:

New to Type 1 Diabetes

Living with Diabetes

Conferences & Community

News

About CWD

New to Type 1 Diabetes
Living with Diabetes
Conferences & Community
CWD Answers
News
About CWD
Donate to CWD
Search for:

Archives

Research News

advertisement

February 18, 2009

Medium Chain Fatty Acids Improve Cognitive Function in Intensively Treated Type 1 Diabetic Patients and Support in vitro Synaptic Transmission During Acute Hypoglycemia.
Avosentan Reduces Albumin Excretion in Diabetics with Macroalbuminuria. See also Experimental Endothelin Antagonist Reduces Diabetic Kidney Disease.
Specificity of islet cell autoantibodies and coexistence with other organ specific autoantibodies in type 1 diabetes mellitus.
Erythropoietin during hypoglycaemia in type 1 diabetes: Relation to basal renin-angiotensin system activity and cognitive function.
Exendin-4 treatment of nonobese diabetic mice increases beta-cell proliferation and fractional insulin reactive area.
Immune markers of disease and therapeutic intervention in type 1 diabetes.
Towards a curative therapy in type 1 diabetes: remission of autoimmunity, maintenance and augmentation of beta cell mass.
Analytical Methods for the Retrieval and Interpretation of Continuous Glucose Monitoring Data in Diabetes.
Graphical and Numerical Evaluation of Continuous Glucose Sensing Time Lag.

February 11, 2009

A Feedforward-Feedback Glucose Control Strategy for Type 1 Diabetes Mellitus. Free full text available in HTML and PDF formats.
The role of toll-like receptor pathways in the mechanism of type 1 diabetes.
Perinatal risk factors in young adult-onset type 1 and type 2 diabetes – a population-based case-control study.
Protection of synapses against Alzheimer’s-linked toxins: Insulin signaling prevents the pathogenic binding of A-beta oligomers. Free full text available in PDF format. See also Insulin is a Possible New Treatment for Alzheimer’s, Insulin May Protect Mind, Memory; Diabetes Drugs Protect Against Alzheimer’s-Related Memory Damage, and A Surprising Link Between Diabetes and Alzheimer’s.

January 28, 2009

Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells. Free full text available in HTML and PDF formats. See also Commentary – Insulin analogues: fears, facts and fantasies, also available in PDF format.
Human cord blood stem cell-modulated regulatory T lymphocytes reverse the autoimmune-caused type 1 diabetes in nonobese diabetic (NOD) mice. Free full text available in HTML and PDF formats.
The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: The Twenty-five-Year Incidence of Macular Edema in Persons with Type 1 Diabetes.
Long-term hyperglycaemia impairs vascular smooth muscle cell function in women with type 1 diabetes mellitus.
Plasma advanced glycation endproduct, methylglyoxal-derived hydroimidazolone is elevated in young, complication-free patients with Type 1 diabetes.
Detection of nocturnal hypoglycemic episodes (natural occurrence) in children with Type 1 diabetes using an optimal Bayesian neural network algorithm.

January 21, 2009

GAD-Alum Treatment Seems Effective in Slowing Residual Beta-Cell Function Loss. Free full text available in PDF format.
Central nervous system function in youth with type 1 diabetes 12 years after disease onset.
Selective Loss of Inner Retinal Layer Thickness in Type 1 Diabetic Patients with Minimal Diabetic Retinopathy.
Rapamycin Prevents and Breaks the Anti-CD3�Induced Tolerance in NOD Mice.
The protective effect of simvastatin against low dose streptozotocin induced type 1 diabetes in mice is independent of inhibition of HMG-CoA reductase.
Bone inflammation and altered gene expression with type I diabetes early onset.
Efficient differentiation of insulin-producing cells from skin-derived stem cells.
Encapsulated porcine islet transplantation: an evolving therapy for the treatment of type I diabetes.

January 14, 2009

Correction of diabetes in primates by macroencapsulated pig islets.
Prolonged survival of pig islets xenograft by adenovirus-mediated expression of either the membrane-bound human FasL or the human decoy Fas antigen gene.
Intraperitoneal insulin infusion versus islet transplantation: comparative study in patients with type 1 diabetes.
Genome-wide scan for linkage to type 1 diabetes in 2,496 multiplex families from the Type 1 Diabetes Genetics Consortium.
Intranasal Insulin Ameliorates Experimental Diabetic Neuropathy.
The incremental value of the pancreas allograft to the survival of Simultaneous Pancreas-Kidney transplant recipients.
Exercise Training During Diabetes Attenuates Cardiac Ryanodine Receptor Dysregulation.
Analysis of islet inflammation in human type 1 diabetes.
Childhood BMI trajectories and the risk of developing young adult-onset diabetes.

January 7, 2009

Can We Learn From Viruses How to Prevent Type 1 Diabetes?
The Environmental Determinants of Diabetes in the Young (TEDDY) Study.
Diabetogenic effects of the most prevalent enteroviruses in Finnish sewage.
Variations in incidence of type 1 diabetes in different municipalities of stockholm.
Risk conferred by HLA-DR and DQ for type 1 diabetes in 0-35-year age group in Sweden.
Exendin-4 therapy in NOD mice with new-onset diabetes increases regulatory T cell frequency.
Leaking gut in type 1 diabetes.
Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides.
Antigen specific treatment for the inhibition and remission of type 1 diabetes.
Review series on helminths, immune modulation and the hygiene hypothesis: how might infection modulate the onset of type 1 diabetes?
Is population mixing associated with childhood type 1 diabetes in Canterbury, New Zealand?
Role of increased ROS dissipation in prevention of T1D.
Effect of Parental Type 2 Diabetes on Offspring With Type 1 Diabetes.

December 31, 2008

Lentivectors encoding immunosuppressive proteins genetically engineer pancreatic beta-cells to correct diabetes in allogeneic mice.
A multi-year analysis of islet transplantation compared with intensive medical therapy on progression of complications in type 1 diabetes.
Islet transplantation with alemtuzumab induction and calcineurin-free maintenance immunosuppression results in improved short- and long-term outcomes.
Current status of islet cell transplantation.
Islet cell transplantation for the treatment of type 1 diabetes in the USA.
Accumulation of autoreactive effector T cells and allo-specific regulatory T cells in the pancreas allograft of a type 1 diabetic recipient.

December 24, 2008

Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. See also Breakthrough In Understanding Development Of Type 1 Diabetes
Longitudinal observation of parechovirus in stool samples from Norwegian infants. See also Common infant virus may trigger type 1 diabetes.
Type 1 diabetes, the A1 milk hypothesis and vitamin D deficiency.
Impact of Lifestyle and Dietary Habits on Hypovitaminosis D in Type 1 Diabetes Mellitus and Healthy Children from Qatar, a Sun-Rich Country.
Retinal vessel response to flicker light in children and adolescents with type 1 diabetes mellitus and overweight or obesity.
Evaluation of quality of life after simultaneous pancreas and kidney transplantation from living donors using short form 36.
Hyperglycaemia is associated with changes in the regional concentrations of glucose and myo-inositol within the brain.
Production of beta-cells from human embryonic stem cells.
Can beta-cells be derived from exocrine pancreas?

December 17, 2008

The “Metabolic Memory”: Is More than Just Tight Glucose Control Necessary to Prevent Diabetic Complications? Free full text available in PDF format.
Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. See also VTT – New scientific knowledge on juvenile diabetes: Metabolic disturbances indicate progress of the disease even years in advance.
Poorly controlled type 1 diabetes is associated with altered glutathione homeostasis in adolescents: apparent resistance to N-acetylcysteine supplementation.
Long-term trends in the incidence of type 1 diabetes in Denmark: the seasonal variation changes over time.
Subcutaneous transplantation of embryonic pancreas for correction of type 1 diabetes.
A Novel Non-invasive Breath Test Method For Screening Persons At Risk For Diabetes.

December 10, 2008

Effects of a controlled hypoglycaemia test on QTc in adolescents with Type 1 diabetes.
Association between reduced pulmonary diffusing capacity and cardiac autonomic dysfunction in Type 1 diabetes.
Induction of innate immune response through TLR2 and dectin 1 prevents type 1 diabetes.
Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia.
High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study. See also Vitamin B1 could reverse early-stage kidney disease in diabetes patients.
Dipeptidyl Peptidase IV Inhibition with MK0431 Improves Islet Graft Survival in Diabetic NOD Mice Partially via T-cell Modulation.
Phenotypic Type 2 Diabetes in Obese Youth: Insulin Sensitivity and Secretion in Islet-cell Antibody Negative vs. Antibody Positive Patients.
Antecedent hypoglycemia impairs autonomic cardiovascular function – implications for rigorous glycemic control.
Hypertriglyceridaemia is associated with an increased likelihood of albuminuria in extreme duration (> 50 years) Type 1 diabetes.

« Previous
1
…
71
72
73
74
75
…
94
Next »

advertisement

Last Updated: Wednesday, June 18, 2025 16:00:30 UTC

This internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

Terms of Use

About Us

Contact Us
- Contact Us
- Submit a Question

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes, EIN #46-3704802), a 501c3 not-for-profit organization, which is responsible for its contents. By using this site, you agree to our Terms of Use, Legal Notice and Privacy Policy.

Children with Diabetes.com © 1995-2025 | Comments and Feedback | All Rights Reserved.

Social

Four-Star Rating Badge - Full Color

DK Popup

This is a popup.

Submit Your Story

If you’d like your story to be considered for inclusion on our website, please fill out the form below.

Name*
First Last
Email*
Enter Email Confirm Email
Address
State / Province / Region Country

Please let us know about where you live.
Date of Birth*
Month
Day
Year
We ask for your birth date so that we can limit what is used on the website if you are under 18.
Date Diagnosed
Month
Day
Year
If you don't know the exact day, don't worry. Just choose the correct month and/or correct year and note this in your story.
Your Story*
Please tell us about yourself and your connection to diabetes.
Your Photo
Accepted file types: jpg, jpeg, png, Max. file size: 25 MB.
If you have a photo, upload it here.
Short Bio
Please include a short bio of yourself so we can consider it for inclusion with the story. This will appear underneath your photo.
Consent to Use My Story and Photo*
I agree with terms below.
By submitting my information, photo, and/or video, I give Children with Diabetes permission to use my story, imagery, photograph(s), and/or video(s), in its promotional materials and publicity efforts. I understand that the imagery may be used in, but not limited to, a publication, print ad, direct-mail piece, electronic media, or other form or promotion; and that my name and additional information collected by the organization may be used in conjunction with the image(s). I release Children with Diabetes from liability for any violation of any personal or proprietary right I may have in connection with such use.

Contact Us

Help Us Understand You Better.

Please answer a few questions to help us understand how best to serve you. You are not required to answer, but we hope you will. This information will be collated and may be published on our website periodically, or may be used for publication, but we will use composite data only. We do not maintain any individual data from these items. If you ask another question at a later time, please fill this out each time.

This form is just for questions related to diabetes care. If you have questions about anything else related to Children with Diabetes, please use our Contact Us form.
This question is on behalf of:
The question applies to this age group:
This question relates to:
We've had diabetes for:
We use this treatment for diabetes:
We have the following insurance:
We receive diabetes care from:
I'm asking this question because:
Type in Your Question Here.
What is your email address?
If you would like to have the answer emailed to you, please include your email address.
Where do you live?
Please tell us where you live (city, state, and country). This information can help us answer your question.
What is your question?*
To preserve confidentiality, we strongly recommend that you do not include in your question any information that identifies you, your child, or any other individual. Please note: questions that are published may be edited for space and clarity.
Name
This field is for validation purposes and should be left unchanged.

First Name*
Last Name*
Email*
What is your connection to type 1 diabetes?*
- I have type 1 diabetes
- I have a child with type 1 diabetes
- I have type 1 and have a child with type 1
- I am a health care professional
- Other
Name
This field is for validation purposes and should be left unchanged.